Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Maria Eduarda Bento Leal"'
Autor:
Fernanda Costas Casal de Faria, Chaquip D. Netto, Paulo Rr Costa, Maria Eduarda Bento Leal, Paula Sabbo Bernardo, Marcos Barcelos de Pinho, Raquel Ciuvalschi Maia
Publikováno v:
Archives of Clinical and Biomedical Research.
Chronic myeloid leukemia (CML), a myeloproliferative disorder characterized by the BCR-ABL oncoprotein, presents its treatment based on tyrosine kinase inhibitors (TKIs), mainly imatinib. However, despite its clinical success, almost 30% of all CML p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d5a6d6504887e3bf1dda1cdc1eb26e1
https://doi.org/10.26502/acbr.50170111
https://doi.org/10.26502/acbr.50170111
Autor:
Fernanda Costas C, de Faria, Maria Eduarda Bento, Leal, Paula Sabbo, Bernardo, Paulo R R, Costa, Raquel C, Maia
Publikováno v:
Anti-cancer agents in medicinal chemistry. 15(3)
Chronic myeloid leukemia (CML), a myeloproliferative disorder characterized by the BCR-ABL oncoprotein, presents its treatment based on tyrosine kinase inhibitors (TKIs), mainly imatinib. However, despite its clinical success, almost 30% of all CML p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::665fbcce2b177b12302a4452798b307c
https://pubmed.ncbi.nlm.nih.gov/25964959
https://pubmed.ncbi.nlm.nih.gov/25964959